Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 5/6 |
Narratives
BetaNarratives bring a range of perspectives from our community.
Warren
Based on Analyst Price Targets
Price at publication US$76.42
Updated
CVS Health Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$57.44 |
52 Week High | US$83.25 |
52 Week Low | US$53.70 |
Beta | 0.55 |
1 Month Change | -17.51% |
3 Month Change | -25.50% |
1 Year Change | -16.54% |
3 Year Change | -34.22% |
5 Year Change | 9.37% |
Change since IPO | 8,649.14% |
Recent News & Updates
CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04Recent updates
CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665
Dec 13We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt
Dec 08CVS Health: A Good Fit To Buffett's 10x Pretax Rule
Dec 07CVS Health: Not One Dividend Cut In 30 Years And A Good Upside
Nov 27CVS Health: All Eyes On December Investor Day
Nov 21CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work
Oct 26CVS Health: 'Only' A Fair Company For A Wonderful Price?
Oct 20CVS Health Offers Recession-Resistant Growth With Transformation
Oct 05CVS Stock: The Risk-Reward Is In A Better Place
Sep 18Shareholder Returns
CVS | US Healthcare | US Market | |
---|---|---|---|
7D | 2.1% | 0.09% | -0.2% |
1Y | -16.5% | 6.9% | 28.2% |
Return vs Industry: CVS underperformed the US Healthcare industry which returned 6.9% over the past year.
Return vs Market: CVS underperformed the US Market which returned 28.2% over the past year.
Price Volatility
CVS volatility | |
---|---|
CVS Average Weekly Movement | 5.6% |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 5.9% |
10% most volatile stocks in US Market | 16.0% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: CVS's share price has been volatile over the past 3 months.
Volatility Over Time: CVS's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
CVS fundamental statistics | |
---|---|
Market cap | US$71.96b |
Earnings (TTM) | US$7.32b |
Revenue (TTM) | US$359.66b |
9.8x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CVS income statement (TTM) | |
---|---|
Revenue | US$359.66b |
Cost of Revenue | US$307.32b |
Gross Profit | US$52.34b |
Other Expenses | US$45.02b |
Earnings | US$7.32b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.83 |
Gross Margin | 14.55% |
Net Profit Margin | 2.04% |
Debt/Equity Ratio | 86.5% |
How did CVS perform over the long term?
See historical performance and comparison